Journal of Clinical Investigation,
Journal Year:
2024,
Volume and Issue:
134(10)
Published: March 7, 2024
Development
of
effective
strategies
to
manage
the
inevitable
acquired
resistance
osimertinib,
an
approved
3rd
generation
EGFR
inhibitor
for
treatment
mutant
(EGFRm)
non-small
cell
lung
cancer
(NSCLC),
is
urgently
needed.
This
study
reported
that
DNA
topoisomerase
II
(Topo
II)
inhibitors,
doxorubicin
and
etoposide
(VP-16)
synergistically
decreased
survival
with
enhanced
induction
damage
apoptosis
in
osimertinib-resistant
cells,
suppressed
growth
tumors,
delayed
emergence
osimertinib
resistance.
Mechanistically,
Topo
IIα
levels
EGFRm
NSCLC
cells
by
facilitating
FBXW7-mediated
proteasomal
degradation,
resulting
damage;
these
effects
were
lost
lines
possessing
elevated
IIα.
elevation
was
also
detected
majority
tissues
relapsed
from
EGFR-TKI
treatment.
Enforced
expression
ectopic
TOP2A
gene
sensitive
conferred
whereas
knockdown
restored
their
response
undergo
osimertinib-induced
apoptosis.
Together,
results
reveal
essential
role
inhibition
mediating
therapeutic
efficacy
against
NSCLC,
providing
scientific
rationale
targeting
osimertinib.
Cell,
Journal Year:
2023,
Volume and Issue:
186(14), P. 3013 - 3032.e22
Published: June 22, 2023
Mitochondrial
DNA
(mtDNA)
is
a
potent
agonist
of
the
innate
immune
system;
however,
exact
immunostimulatory
features
mtDNA
and
kinetics
detection
by
cytosolic
nucleic
acid
sensors
remain
poorly
defined.
Here,
we
show
that
mitochondrial
genome
instability
promotes
Z-form
accumulation.
Z-DNA
binding
protein
1
(ZBP1)
stabilizes
nucleates
complex
containing
cGAS,
RIPK1,
RIPK3
to
sustain
STAT1
phosphorylation
type
I
interferon
(IFN-I)
signaling.
Elevated
mtDNA,
ZBP1
expression,
IFN-I
signaling
are
observed
in
cardiomyocytes
after
exposure
Doxorubicin,
first-line
chemotherapeutic
agent
induces
frequent
cardiotoxicity
cancer
patients.
Strikingly,
mice
lacking
or
protected
from
Doxorubicin-induced
cardiotoxicity.
Our
findings
reveal
as
cooperative
partner
for
cGAS
sustains
responses
highlight
potential
target
heart
failure
other
disorders
where
stress
contributes
interferon-related
pathology.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(15), P. 8412 - 8412
Published: July 29, 2022
PARP
inhibitors
are
the
first
clinically
approved
drugs
that
were
developed
based
on
synthetic
lethality.
have
shown
promising
outcomes
since
their
clinical
applications
and
recently
been
as
maintenance
treatment
for
cancer
patients
with
BRCA
mutations.
also
exhibit
positive
results
even
in
without
homologous
recombination
(HR)
deficiency.
Therapeutic
effects
successfully
achieved;
however,
development
of
resistance
was
unavoidable.
Approximately
40–70%
likely
to
develop
resistance.
Here,
we
describe
mechanisms
action
inhibitors,
causes
resistance,
various
efforts
overcome
Particularly,
determined
survival
probability
according
expression
patterns
genes
associated
HR
restoration,
which
critical
inhibitor
Furthermore,
discuss
innovative
attempts
degrade
proteins
by
chemically
modifying
inhibitors.
These
would
enhance
efficacy
or
expand
scope
usage.
Science,
Journal Year:
2024,
Volume and Issue:
385(6710)
Published: June 20, 2024
Using
CRISPR-Cas9
nicking
enzymes,
we
examined
the
interaction
between
replication
machinery
and
single-strand
breaks,
one
of
most
common
forms
endogenous
DNA
damage.
We
show
that
fork
collapse
at
leading-strand
nicks
generates
resected
single-ended
double-strand
breaks
(seDSBs)
are
repaired
by
homologous
recombination
(HR).
If
these
seDSBs
not
promptly
repaired,
arrival
adjacent
forks
creates
double-ended
DSBs
(deDSBs),
which
could
drive
genomic
scarring
in
HR-deficient
cancers.
deDSBs
can
also
be
generated
directly
when
bypasses
lagging-strand
nicks.
Unlike
produced
independently
replication,
end
resection
nick-induced
is
BRCA1-independent.
Nevertheless,
BRCA1
antagonizes
53BP1
suppression
RAD51
filament
formation.
These
results
highlight
distinctive
mechanisms
maintain
stability.
Journal of Cancer,
Journal Year:
2024,
Volume and Issue:
15(7), P. 1916 - 1928
Published: Jan. 1, 2024
Background:
Accumulating
evidence
indicates
that
non-coding
RNAs
(ncRNA),
including
long
(lncRNAs)
and
circular
(circRNAs),
can
function
as
competitive
endogenous
(ceRNAs)
by
binding
to
microRNAs
(miRNAs)
regulating
host
gene
expression
at
the
transcriptional
or
post-transcriptional
level.Dysregulation
in
ceRNA
network
regulation
has
been
implicated
occurrence
development
of
cancer.However,
lncRNA/circRNA-miRNA-mRNA
regulatory
is
still
lacking
nasopharyngeal
carcinoma
(NPC).Methods:
Differentially
expressed
genes
(DEGs)
were
obtained
from
our
previous
sequencing
data
Gene
Expression
Omnibus
(GEO).Gene
Ontology
(GO)
Kyoto
Encyclopedia
Genes
Genomes
pathway
(KEGG)
used
explore
biological
functions
these
common
DEGs.Through
a
series
bioinformatic
analyses,
was
established.In
additional,
external
GSE102349
test
prognostic
value
hub
mRNAs
through
Kaplan-Meier
method.Results:
We
successfully
constructed
NPC,
consisting
16
lncRNAs,
6
miRNAs,
3
circRNAs
10
found
three
(TOP2A,
ZWINT,
TTK)
significantly
associated
with
overall
survival
time
(OS)
patients.
Conclusion:The
revealed
this
study
may
help
comprehensively
elucidate
mechanisms
driving
provide
novel
candidate
biomarkers
for
evaluating
prognosis
NPC.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 19, 2025
Abstract
Type
IA
topoisomerases
(TopoIAs)
are
present
in
all
living
organisms.
They
resolve
DNA/RNA
catenanes,
knots
and
supercoils
by
breaking
rejoining
single-stranded
segments
allowing
the
passage
of
another
nucleic
acid
segment
through
break.
Topoisomerase
III-β
(TOP3B),
only
RNA
topoisomerase
metazoans,
promotes
R-loop
disassembly
translation
mRNAs.
Defects
TOP3B
lead
to
severe
neurological
diseases.
We
a
series
cryo-EM
structures
human
with
its
cofactor
TDRD3
during
cleavage
DNA
or
RNA,
thus
elucidating
roles
divalent
metal
ions
key
enzyme
residues
each
step
catalytic
cycle.
also
obtained
structure
an
open-gate
configuration
that
addresses
long-standing
question
strand-passage
mechanism.
Our
studies
reveal
how
catalyzes
both
relaxation,
while
TOP3A
acts
on
DNA.
Cell Reports,
Journal Year:
2022,
Volume and Issue:
40(2), P. 111067 - 111067
Published: July 1, 2022
The
present
study
demonstrates
how
TOP3B
is
involved
in
resolving
R-loops.
We
observed
elevated
R-loops
knockout
cells
(TOP3BKO),
which
are
suppressed
by
transfection.
R-loop-inducing
agents,
the
topoisomerase
I
inhibitor
camptothecin,
and
splicing
pladienolide-B
also
induce
higher
TOP3BKO
cells.
Camptothecin-
pladienolide-B-induced
concurrent
with
induction
of
cleavage
complexes
(TOP3Bccs).
RNA/DNA
hybrid
IP-western
blotting
show
that
physically
associated
Biochemical
assays
using
recombinant
oligonucleotides
mimicking
cleaves
single-stranded
DNA
displaced
R-loop
RNA-DNA
duplex.
IP-mass
spectrometry
experiments
reveal
interacts
helicase
DDX5
independently
TDRD3.
Finally,
we
demonstrate
epistatic
a
pathway
parallel
senataxin.
propose
decatenation
model
for
resolution
TOP3B-DDX5
protecting
from
R-loop-induced
damage.
Molecular Cell,
Journal Year:
2023,
Volume and Issue:
84(1), P. 70 - 79
Published: Dec. 15, 2023
Genome
damage
and
transcription
are
intimately
linked.
Tens
to
hundreds
of
thousands
DNA
lesions
arise
in
each
cell
day,
many
which
can
directly
or
indirectly
impede
transcription.
Conversely,
the
process
gene
expression
is
itself
a
source
endogenous
as
result
susceptibility
single-stranded
damage,
conflicts
with
replication
machinery,
engagement
by
cells
topoisomerases
base
excision
repair
enzymes
regulate
initiation
progression
Although
such
processes
tightly
regulated
normally
accurate,
on
occasion,
they
become
abortive
leave
behind
breaks
that
drive
genome
rearrangements,
instability,
death.